Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) - Total Assets

Latest as of September 2025: Rs2.99 Billion INR ≈ $32.34 Million USD

Based on the latest financial reports, Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) holds total assets worth Rs2.99 Billion INR (≈ $32.34 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See JAGSNPHARM net asset value for net asset value and shareholders' equity analysis.

Jagsonpal Pharmaceuticals Limited - Total Assets Trend (2006–2025)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's total assets have evolved over time, based on quarterly financial data.

Jagsonpal Pharmaceuticals Limited - Asset Composition Analysis

Current Asset Composition (March 2025)

Jagsonpal Pharmaceuticals Limited's total assets of Rs2.99 Billion consist of 57.9% current assets and 42.1% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	46.3%
Accounts Receivable	Rs131.76 Million	4.7%
Inventory	Rs152.00 Million	5.5%
Property, Plant & Equipment	Rs847.61 Million	30.5%
Intangible Assets	Rs759.24 Million	27.3%
Goodwill	Rs96.93 Million	3.5%

Asset Composition Trend (2006–2025)

This chart illustrates how Jagsonpal Pharmaceuticals Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see JAGSNPHARM market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Jagsonpal Pharmaceuticals Limited's current assets represent 57.9% of total assets in 2025, a decrease from 74.1% in 2006.
Cash Position: Cash and equivalents constituted 46.3% of total assets in 2025, up from 2.8% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is property, plant & equipment at 30.5% of total assets.

Jagsonpal Pharmaceuticals Limited Competitors by Total Assets

Key competitors of Jagsonpal Pharmaceuticals Limited based on total assets are shown below.

Company	Country	Total Assets
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥31.46 Billion
Yuhan Corp. KO:000100	Korea	₩3.05 Trillion
Tasly Pharmaceutical Group Co Ltd SHG:600535	China	CN¥15.34 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥15.32 Billion
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	China	CN¥10.96 Billion
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	China	CN¥1.54 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion

Jagsonpal Pharmaceuticals Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	6.07	2.95	2.60
Quick Ratio	5.59	2.60	2.24
Cash Ratio	0.00	0.00	0.00
Working Capital	Rs1.69 Billion	Rs917.95 Million	Rs682.07 Million

Jagsonpal Pharmaceuticals Limited - Advanced Valuation Insights

This section examines the relationship between Jagsonpal Pharmaceuticals Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	4.84
Latest Market Cap to Assets Ratio	0.05
Asset Growth Rate (YoY)	28.2%
Total Assets	Rs2.78 Billion
Market Capitalization	$152.18 Million USD

Valuation Analysis

Below Book Valuation: The market values Jagsonpal Pharmaceuticals Limited's assets below their book value (0.05x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Jagsonpal Pharmaceuticals Limited's assets grew by 28.2% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Jagsonpal Pharmaceuticals Limited (2006–2025)

The table below shows the annual total assets of Jagsonpal Pharmaceuticals Limited from 2006 to 2025.

Year	Total Assets	Change
2025-03-31	Rs2.78 Billion ≈ $30.09 Million	+28.18%
2024-03-31	Rs2.17 Billion ≈ $23.48 Million	+11.35%
2023-03-31	Rs1.95 Billion ≈ $21.08 Million	+15.73%
2022-03-31	Rs1.68 Billion ≈ $18.22 Million	+2.59%
2021-03-31	Rs1.64 Billion ≈ $17.76 Million	+11.74%
2020-03-31	Rs1.47 Billion ≈ $15.89 Million	+8.23%
2019-03-31	Rs1.36 Billion ≈ $14.68 Million	+4.60%
2018-03-31	Rs1.30 Billion ≈ $14.04 Million	-8.97%
2017-03-31	Rs1.43 Billion ≈ $15.42 Million	-10.47%
2016-03-31	Rs1.59 Billion ≈ $17.23 Million	+3.28%
2015-03-31	Rs1.54 Billion ≈ $16.68 Million	-1.30%
2014-03-31	Rs1.56 Billion ≈ $16.90 Million	+2.13%
2013-03-31	Rs1.53 Billion ≈ $16.55 Million	-1.98%
2012-03-31	Rs1.56 Billion ≈ $16.88 Million	+14.18%
2011-03-31	Rs1.37 Billion ≈ $14.79 Million	+10.94%
2010-03-31	Rs1.23 Billion ≈ $13.33 Million	+0.38%
2009-03-31	Rs1.23 Billion ≈ $13.28 Million	-5.74%
2008-03-31	Rs1.30 Billion ≈ $14.09 Million	-11.68%
2007-03-31	Rs1.47 Billion ≈ $15.95 Million	+4.19%
2006-03-31	Rs1.42 Billion ≈ $15.31 Million	--

About Jagsonpal Pharmaceuticals Limited

NSE:JAGSNPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$152.18 Million

Rs14.07 Billion INR

Market Cap Rank

#17588 Global

#911 in India

Share Price

Rs210.37

Change (1 day)

+0.74%

52-Week Range

Rs161.07 - Rs292.75

All Time High

Rs761.20